<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39406981</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1568-5608</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>16</Day></PubDate></JournalIssue><Title>Inflammopharmacology</Title><ISOAbbreviation>Inflammopharmacology</ISOAbbreviation></Journal><ArticleTitle>Vitamin D: A key player in COVID-19 immunity and lessons from the pandemic to combat immune-evasive variants.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10787-024-01578-w</ELocationID><Abstract><AbstractText>As of the 7<sup>th</sup> of July 2024, 775,754,322 confirmed cases of COVID-19, including 7,053,902 deaths worldwide, had been reported to the WHO (World Health Organization). Nevertheless, untill the 15<sup>th</sup> of July 2024, a total of 13,578,710,228 vaccine doses had been administered, with almost no country spared from COVID-19 attacks. The pathophysiology of this virus is complicated, and several symptoms require a deep understanding of the actual mechanisms. It is unclear why some patients develop severe symptoms while others do not, although literature suggests a role for vitamin D. Vitamin D plays a crucial role in the infection or in ameliorating the severity of symptoms. The mechanism of action of vitamin D and vitamin D deficiency (VDD) is well understood. VDD is associated with increased hospitalization of severely ill patients and increased levels of COVID-19-caused mortality. Recent studies suggest that vitamin D levels and genetic variations in the vitamin D receptor (VDR) gene significantly impact the severity and outcomes of COVID-19, especially in the infections caused by Delta and Omicron variants. Furthermore, VDD causes immune system dysregulation upon infection with SARS-CoV-2, indicating that vitamin D sufficiency is crucial in fighting against COVID-19 infection. The therapeutic effect of vitamin D raises interest in its potential role as a prophylactic and treatment adjunct. We evaluate the immunomodulatory effects of vitamin D and its ability to enhance the efficacy of new antiviral drugs like molnupiravir and paxlovid against SARS-CoV-2. This review discusses the role of vitamin D sufficiency and VDD in COVID-19 initiation and progression, emphasizing the molecular mechanisms by which vitamin D exerts its actions as a proactive step for the next pandemic. However, there is still no clear evidence of vitamin D's impact on prevention and treatment, leading to contradictory findings. Therefore, large-scale randomized trials are required to reach a definitive conclusion. A bibliometric analysis of publications related to vitamin D, immunity, and COVID-19 revealed a significant increase in research activity in this area, particularly in 2020-2024, underscoring the growing recognition of vitamin D's potential role in the context of the pandemic.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sabit</LastName><ForeName>Hussein</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medical Biotechnology, College of Biotechnology, Misr University for Science and Technology, P. O. Box 77, Giza, Egypt. hussein.sabit@must.edu.eg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdel-Ghany</LastName><ForeName>Shaimaa</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Environmental Biotechnology, College of Biotechnology, Misr University for Science and Technology, P. O. Box 77, Giza, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdallah</LastName><ForeName>Mahmoud S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Clinical Pharmacy, Faculty of Pharmacy, University of Sadat City (USC), Sadat City, 32897, Egypt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of PharmD, Faculty of Pharmacy, Jadara University, Irbid, 21110, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abul-Maaty</LastName><ForeName>Osama</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Faculty of Science, Mansoura University, Mansoura, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khoder</LastName><ForeName>Ahmed I</ForeName><Initials>AI</Initials><AffiliationInfo><Affiliation>Scientific Office, Egyptian Society of Pharmacogenomics and Personalized Medicine (ESPM), Cairo, Egypt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Molecular Biology Department, Genetic Engineering and Biotechnology Research Institute, University of Sadat City, Sadat City, Egypt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pharmacology and Toxicology Department, Faculty of Pharmacy, Menoufia University, Shebin El-Koum, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shoman</LastName><ForeName>Nabil A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Ahram Canadian University, Giza, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farrag</LastName><ForeName>Mohamed Sameh</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Scientific Office, Egyptian Society of Pharmacogenomics and Personalized Medicine (ESPM), Cairo, Egypt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague Ke Karlovu 2, 128 08, Praha 2, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martasek</LastName><ForeName>Pavel</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague Ke Karlovu 2, 128 08, Praha 2, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noreddin</LastName><ForeName>Ayman M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Scientific Office, Egyptian Society of Pharmacogenomics and Personalized Medicine (ESPM), Cairo, Egypt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Pharmacy, Faculty of Pharmacy, Ahram Canadian University (ACU), 6th of October City, Giza, 12566, Egypt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, School of Medicine, University of California-Irvine, Irvine, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nazih</LastName><ForeName>Mahmoud</ForeName><Initials>M</Initials><Identifier Source="ORCID">0009-0000-0522-399X</Identifier><AffiliationInfo><Affiliation>Scientific Office, Egyptian Society of Pharmacogenomics and Personalized Medicine (ESPM), Cairo, Egypt. Mahmoud.Nazih5698@pharm.aun.edu.eg.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Pharmacy, Faculty of Pharmacy, Ahram Canadian University (ACU), 6th of October City, Giza, 12566, Egypt. Mahmoud.Nazih5698@pharm.aun.edu.eg.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Al Ryada University for Science and Technology (RST), ElMehwar ElMarkazy-2, Cairo - Alex desert RD K92, Sadat City, 16504, Egypt. Mahmoud.Nazih5698@pharm.aun.edu.eg.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Inflammopharmacology</MedlineTA><NlmUniqueID>9112626</NlmUniqueID><ISSNLinking>0925-4692</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">COVID-19 variants</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Vitamin D</Keyword><Keyword MajorTopicYN="N">Vitamin D deficiency</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>23</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39406981</ArticleId><ArticleId IdType="doi">10.1007/s10787-024-01578-w</ArticleId><ArticleId IdType="pii">10.1007/s10787-024-01578-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abdollahi A, Kamali Sarvestani H, Rafat Z, Ghaderkhani S, Mahmoudi-Aliabadi M, Jafarzadeh B et al (2021) The association between the level of serum 25 (OH) vitamin D, obesity, and underlying diseases with the risk of developing COVID-19 infection: a case–control study of hospitalized patients in Tehran. Iran J Med Virol 93(4):2359–2364</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26726</ArticleId></ArticleIdList></Reference><Reference><Citation>Abraham J, Dowling K, Florentine S (2021) Can optimum solar radiation exposure or supplemented vitamin d intake reduce the severity of COVID-19 symptoms? Int J Environ Res Public Health 18(2):740</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18020740</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed F (2020) A network-based analysis reveals the mechanism underlying vitamin d in suppressing cytokine storm and virus in SARS-CoV-2 infection. Front Immunol 11:590459</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.590459</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed MAS, Atta MNS, Aboul-Seoud MA-L, Tahoun MM, Allah S (2024) Assessment of vitamin d status among Egyptian covid-19 patients. Egypt J Int Med 36(1):63</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43162-024-00330-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzaman NS, Dawson-Hughes B, Nelson J, D’Alessio D, Pittas AG (2016) Vitamin D status of black and white Americans and changes in vitamin D metabolites after varied doses of vitamin D supplementation. Am J Clin Nutr 104(1):205–214</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/ajcn.115.129478</ArticleId></ArticleIdList></Reference><Reference><Citation>Ames BN, Grant WB, Willett WC (2021) Does the high prevalence of vitamin D deficiency in African Americans contribute to health disparities? Nutrients 13(2):499</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13020499</ArticleId></ArticleIdList></Reference><Reference><Citation>Annweiler C, Cao Z, Sabatier JM (2020) Point of view: Should COVID-19 patients be supplemented with vitamin D? Maturitas 140:24–26</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.maturitas.2020.06.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Annweiler C, Beaudenon M, Gautier J, Gonsard J, Boucher S, Chapelet G et al (2022) High-dose versus standard-dose vitamin D supplementation in older adults with COVID-19 (COVIT-TRIAL): a multicenter, open-label, randomized controlled superiority trial. PLoS Med 19(5):e1003999</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003999</ArticleId></ArticleIdList></Reference><Reference><Citation>Arboleda JF, Urcuqui-Inchima S (2020) Vitamin D supplementation: a potential approach for coronavirus/COVID-19 therapeutics? Front Immunol 11:1523</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01523</ArticleId></ArticleIdList></Reference><Reference><Citation>Baktash V, Hosack T, Patel N, Shah S, Kandiah P, Van den Abbeele K et al (2020) Vitamin D status and outcomes for hospitalised older patients with COVID-19. Postgrad Med J. https://doi.org/10.1136/postgradmedj-2020-138712</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/postgradmedj-2020-138712</ArticleId></ArticleIdList></Reference><Reference><Citation>Barassi A, Pezzilli R, Mondoni M, Rinaldo RF, DavÌ M, Cozzolino M et al (2021) Vitamin D in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients with non-invasive ventilation support. Panminerva Med. https://doi.org/10.23736/S0031-0808.21.04277-4</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S0031-0808.21.04277-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Barker T, Henriksen VT, Rogers VE, Aguirre D, Trawick RH, Lynn Rasmussen G et al (2014) Vitamin D deficiency associates with γ-tocopherol and quadriceps weakness but not inflammatory cytokines in subjects with knee osteoarthritis. Redox Biol 2(C):466–74</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2014.01.024</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassatne A, Basbous M, Chakhtoura M, El Zein O, Rahme M, El-Hajj Fuleihan G (2021) The link between COVID-19 and VItamin D (VIVID): a systematic review and meta-analysis. Metab Clin Exp 119:154753</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2021.154753</ArticleId></ArticleIdList></Reference><Reference><Citation>Benskin LL (2020) A basic review of the preliminary evidence that COVID-19 risk and severity is increased in vitamin D deficiency. Front Public Health 8:513</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.00513</ArticleId></ArticleIdList></Reference><Reference><Citation>Berridge MJ (2017) Vitamin D deficiency and diabetes. Biochem J 474(8):1321–1332</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20170042</ArticleId></ArticleIdList></Reference><Reference><Citation>Bikle DD (2014) Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol 21(3):319–329</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chembiol.2013.12.016</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilezikian JP, Bikle D, Hewison M, Lazaretti-Castro M, Formenti AM, Gupta A et al (2020) Mechanisms in endocrinology: vitamin D and Covid-19. Eur J Endocrinol 183(5):R133–R147</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EJE-20-0665</ArticleId></ArticleIdList></Reference><Reference><Citation>Bishop E, Ismailova A, Dimeloe S, Hewison M, White JH (2021) Vitamin D and immune regulation: antibacterial, antiviral, anti-inflammatory. JBMR plus 5(1):e10405</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbm4.10405</ArticleId></ArticleIdList></Reference><Reference><Citation>Bishop EL, Ismailova A, Dimeloe S, Hewison M, White JH (2021) Vitamin D and immune regulation: antibacterial, antiviral, anti-inflammatory. JBMR Plus 5(1):e10405</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbm4.10405</ArticleId></ArticleIdList></Reference><Reference><Citation>Bornstein SR, Rubino F, Khunti K, Mingrone G, Hopkins D, Birkenfeld AL et al (2020) Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol 8(6):546–550</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(20)30152-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner H, Vitamin D (2021) Supplementation to prevent COVID-19 infections and deaths-accumulating evidence from epidemiological and intervention studies calls for immediate action. Nutrients 13(2):411</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13020411</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown JP, Josse RG (2002) 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 167(10 Suppl):S1-34</Citation></Reference><Reference><Citation>Calder PC, Carr AC, Gombart AF, Eggersdorfer M (2020) Optimal nutritional status for a well-functioning immune system is an important factor to protect against viral infections. Nutrients 12(4):1181</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12041181</ArticleId></ArticleIdList></Reference><Reference><Citation>Camargo CA Jr, Martineau AR (2020) Vitamin D to prevent COVID-19: recommendations for the design of clinical trials. FEBS J 287(17):3689–3692</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.15534</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlberg C, Campbell MJ (2013) Vitamin D receptor signaling mechanisms: integrated actions of a well-defined transcription factor. Steroids 78(2):127–136</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.steroids.2012.10.019</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpagnano GE, Di Lecce V, Quaranta VN, Zito A, Buonamico E, Capozza E et al (2021) Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19. J Endocrinol Invest 44(4):765–771</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-020-01370-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Castillo ME, Costa LME, Barrios JMV, Díaz JFA, Miranda JL, Bouillon R et al (2020) Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: a pilot randomized clinical study. J Steroid Biochem Mol Biol 203:105751</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsbmb.2020.105751</ArticleId></ArticleIdList></Reference><Reference><Citation>Cereda E, Bogliolo L, Klersy C, Lobascio F, Masi S, Crotti S et al (2020) Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospital. Clin Nutr. https://doi.org/10.1016/j.clnu.2020.10.055</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2020.10.055</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandran M, Chan Maung A, Mithal A, Parameswaran R (2020) Vitamin D in COVID-19: dousing the fire or averting the storm?—A perspective from the Asia-Pacific. Osteoporos Sarcopenia 6(3):97–105</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.afos.2020.07.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Christakos S, Dhawan P, Porta A, Mady LJ, Seth T (2011) Vitamin D and intestinal calcium absorption. Mol Cell Endocrinol 347(1–2):25–29</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mce.2011.05.038</ArticleId></ArticleIdList></Reference><Reference><Citation>Crissey SD, Ange KD, Jacobsen KL, Slifka KA, Bowen PE, Stacewicz-Sapuntzakis M et al (2003) Serum concentrations of lipids, Vitamin D metabolites, retinol, retinyl esters, tocopherols and selected carotenoids in twelve captive wild felid species at four zoos. J Nutr 133(1):160–166</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jn/133.1.160</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuschieri S, Grech S (2020) Obesity population at risk of COVID-19 complications. Glob Health Epidemiol Genom 5:e6</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/gheg.2020.6</ArticleId></ArticleIdList></Reference><Reference><Citation>D’Avolio A, Avataneo V, Manca A, Cusato J, De Nicolò A, Lucchini R et al (2020) 25-Hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2. Nutrients 12(5):1359</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12051359</ArticleId></ArticleIdList></Reference><Reference><Citation>de Barros Viana M, Rosário BDA, de Fátima Santana de Nazaré M, Estadella D, Ribeiro DA, de Socorro Barros Viana G (2021) COVID-19 in age-related neurodegenerative diseases: is there a role for vitamin D3 as a possible therapeutic strategy? Rev Neurosci 32(2):235–47</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/revneuro-2020-0074</ArticleId></ArticleIdList></Reference><Reference><Citation>de Las HN, Martín Giménez VM, Ferder L, Manucha W, Lahera V (2020) Implications of oxidative stress and potential role of mitochondrial dysfunction in COVID-19: therapeutic effects of vitamin D. Antioxidants 9(9):897</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9090897</ArticleId></ArticleIdList></Reference><Reference><Citation>De Smet D, De Smet K, Herroelen P, Gryspeerdt S, Martens GA (2021) Serum 25 (OH) D level on hospital admission associated with COVID-19 stage and mortality. Am J Clin Pathol 155(3):381–388</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcp/aqaa252</ArticleId></ArticleIdList></Reference><Reference><Citation>Demir M, Demir F, Aygun H (2021) Vitamin D deficiency is associated with COVID-19 positivity and severity of the disease. J Med Virol. https://doi.org/10.1002/jmv.26832</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26832</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhama K, Patel SK, Natesan S, Vora KS, Iqbal Yatoo M, Tiwari R et al (2020) COVID-19 in the elderly people and advances in vaccination approaches. Hum Vaccin Immunother 16(12):2938–2943</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2020.1842683</ArticleId></ArticleIdList></Reference><Reference><Citation>Dilokpattanamongkol P, Yan C, Jayanama K, Ngamjanyaporn P, Sungkanuparph S, Rotjanapan P (2024) Impact of vitamin D supplementation on the clinical outcomes of COVID-19 pneumonia patients: a single-center randomized controlled trial. BMC Complement Med Ther 24(1):97</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12906-024-04393-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Domazet Bugarin J, Dosenovic S, Ilic D, Delic N, Saric I, Ugrina I et al (2023) Vitamin D supplementation and clinical outcomes in severe COVID-19 patients—randomized controlled trial. Nutrients 15(5):1234</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15051234</ArticleId></ArticleIdList></Reference><Reference><Citation>Domazet Bugarin J, Dosenovic S, Ilic D, Delic N, Saric I, Ugrina I et al (2023) Vitamin D supplementation and clinical outcomes in severe COVID-19 patients—randomized controlled trial. Nutrients 15(5):1234</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15051234</ArticleId></ArticleIdList></Reference><Reference><Citation>Dugald S, Mark L, Ellen C, Caitlyn K, Athanasios P, Tim R et al (2023) Dietary supplements to reduce symptom severity and duration in people with SARS-CoV-2: a double-blind randomised controlled trial. BMJ Open 13(9):e073761</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2023-073761</ArticleId></ArticleIdList></Reference><Reference><Citation>Dusso AS, Brown AJ, Slatopolsky E (2005) Vitamin D. Am J Physiol Renal Physiol 289(1):F8-28</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.00336.2004</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Hddad SS, Sobhy MH, El-Morsy A, Shoman NA, El-Adl K (2024) Quinazolines and thiazolidine-2, 4-dions as SARS-CoV-2 inhibitors: repurposing, in silico molecular docking and dynamics simulation. RSC Adv 14(19):13237–13250</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D4RA02029D</ArticleId></ArticleIdList></Reference><Reference><Citation>Erener S (2020) Diabetes, infection risk and COVID-19. Mol Metab 39:101044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmet.2020.101044</ArticleId></ArticleIdList></Reference><Reference><Citation>Farid N, Rola N, Koch EAT, Nakhoul N (2021) Active vitamin D supplementation and COVID-19 infections: review. Irish J Med Sci 190:1–4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11845-020-02452-8</ArticleId></ArticleIdList></Reference><Reference><Citation>FDA (2021a) Coronavirus (COVID-19) update: FDA authorizes first oral antiviral for treatment of COVID-19. U.S. Food and Drug Administration, December 22, 2021. Available at: https://www.fda.gov/news-events/pressannouncements/coronavirus-covid-19-update-fda-authorizes-first-oral-antiviral-treatment-covid-19 . Accessed 1 July 2024</Citation></Reference><Reference><Citation>FDA (2021b) Coronavirus (COVID-19) update: FDA authorizes additional oral antiviral for treatment of COVID-19 in certain adults. U.S. Food and Drug Administration, December 23, 2021. Available at: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizesadditional-oral-antiviral-treatment-covid-19-certain . Accessed 1 July 2024</Citation></Reference><Reference><Citation>Fetahu IS, Höbaus J, Kállay E (2014) Vitamin D and the epigenome. Front Physiol 5:164</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2014.00164</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallagher JC, Peacock M, Yalamanchili V, Smith LM (2013) Effects of vitamin D supplementation in older African American women. J Clin Endocrinol Metab 98(3):1137–1146</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2012-3106</ArticleId></ArticleIdList></Reference><Reference><Citation>Gambichler T, Bader A, Vojvodic M, Bechara FG, Sauermann K, Altmeyer P et al (2002) Impact of UVA exposure on psychological parameters and circulating serotonin and melatonin. BMC Dermatol 2:6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-5945-2-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorman S, Buckley AG, Ling K-M, Berry LJ, Fear VS, Stick SM et al (2017) Vitamin D supplementation of initially vitamin D-deficient mice diminishes lung inflammation with limited effects on pulmonary epithelial integrity. Physiol Rep 5(15):e13371</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.13371</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL et al (2020) Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients 12(4):988</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12040988</ArticleId></ArticleIdList></Reference><Reference><Citation>Greulich T, Regner W, Branscheidt M, Herr C, Koczulla AR, Vogelmeier CF et al (2017) Altered blood levels of vitamin D, cathelicidin and parathyroid hormone in patients with sepsis—a pilot study. Anaesth Intensive Care 45(1):36–45</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0310057X1704500106</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin G, Hewison M, Hopkin J, Kenny R, Quinton R, Rhodes J et al (2020) Vitamin D and COVID-19: evidence and recommendations for supplementation. R Soc Open Sci 7(12):201912</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsos.201912</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutiérrez OM, Farwell WR, Kermah D, Taylor EN (2011) Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the national health and nutrition examination survey. Osteoporos Int 22(6):1745–1753</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-010-1383-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardwick LL, Jones MR, Brautbar N, Lee DB (1991) Magnesium absorption: mechanisms and the influence of vitamin D, calcium and phosphate. J Nutr 121(1):13–23</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jn/121.1.13</ArticleId></ArticleIdList></Reference><Reference><Citation>Hathcock JN, Shao A, Vieth R, Heaney R (2007) Risk assessment for vitamin D. Am J Clin Nutr 85(1):6–18</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/85.1.6</ArticleId></ArticleIdList></Reference><Reference><Citation>Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS et al (1997) The vitamin D hormone and its nuclear receptor: molecular actions and disease states. J Endocrinol 154(Suppl):S57-73</Citation></Reference><Reference><Citation>Hodgkinson A, Marshall DH, Nordin BE (1979) Vitamin D and magnesium absorption in man. Clin Sci 57(1):121–123</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/cs0570121</ArticleId></ArticleIdList></Reference><Reference><Citation>Holick MF (2007) Vitamin D deficiency. N Engl J Med 357(3):266–281</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra070553</ArticleId></ArticleIdList></Reference><Reference><Citation>Holick MF, Smith E, Pincus S (1987) Skin as the site of vitamin D synthesis and target tissue for 1,25-dihydroxyvitamin D3. Use of calcitriol (1,25-dihydroxyvitamin D3) for treatment of psoriasis. Arch Dermatol 123(12):1677–1683</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archderm.1987.01660360108022</ArticleId></ArticleIdList></Reference><Reference><Citation>Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911–1930</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2011-0385</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossein-nezhad A, Holick MF (2013) Vitamin D for health: a global perspective. Mayo Clin Proc 88(7):720–755</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2013.05.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Hribar CA, Cobbold PH, Church FC (2020) Potential role of vitamin D in the elderly to resist COVID-19 and to slow progression of Parkinson’s disease. Brain Sci 10(5):284</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci10050284</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H, Zheng J, Liu Y, Zhou Q, Peng D (2023) Effect of vitamin D status on adult COVID-19 pneumonia induced by delta variant: a longitudinal, real-world cohort study. Front Med 10:1121256</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1121256</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain A, Bhowmik B, do Vale Moreira NC (2020) COVID-19 and diabetes: knowledge in progress. Diabetes Res Clin Pract 162:108142</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2020.108142</ArticleId></ArticleIdList></Reference><Reference><Citation>Iddir M, Brito A, Dingeo G, Fernandez Del Campo SS, Samouda H, La Frano MR et al (2020) Strengthening the immune system and reducing inflammation and oxidative stress through diet and nutrition: considerations during the COVID-19 crisis. Nutrients 12(6):1562</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12061562</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute of Medicine Committee to Review Dietary Reference Intakes for Vitamin D, Calcium (2011) The National Academies Collection: reports funded by National Institutes of Health. In: Ross AC, Taylor CL, Yaktine AL, Del Valle HB, editors. Dietary reference intakes for calcium and vitamin D. Washington (DC): National Academies Press (US) Copyright © 2011, National Academy of Sciences</Citation></Reference><Reference><Citation>Ish-Shalom S, Segal E, Salganik T, Raz B, Bromberg IL, Vieth R (2008) Comparison of daily, weekly, and monthly vitamin D3 in ethanol dosing protocols for two months in elderly hip fracture patients. J Clin Endocrinol Metab 93(9):3430–3435</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2008-0241</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismailova A, White JH (2022) Vitamin D, infections and immunity. Rev Endocr Metab Disord 23(2):265–277</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11154-021-09679-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain A, Chaurasia R, Sengar NS, Singh M, Mahor S, Narain S (2020) Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers. Sci Rep 10(1):20191</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-77093-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Jäpelt RB, Jakobsen J (2013) Vitamin D in plants: a review of occurrence, analysis, and biosynthesis. Front Plant Sci 4:136</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpls.2013.00136</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaun F, Boesing M, Luethi-Corridori G, Abig K, Bloch N, Giezendanner S et al (2023) Effect of single high dose vitamin D substitution in hospitalized COVID-19 patients with vitamin D deficiency on length of hospital stay. Biomedicines 11(5):1277</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11051277</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones G (2008) Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr 88(2):582s-s586</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/88.2.582S</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones G, Prosser DE, Kaufmann M (2012) 25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D. Arch Biochem Biophys 523(1):9–18</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2011.11.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Judd SE, Tangpricha V (2009) Vitamin D deficiency and risk for cardiovascular disease. Am J Med Sci 338(1):40–44</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MAJ.0b013e3181aaee91</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadambari S, Klenerman P, Pollard AJ (2020) Why the elderly appear to be more severely affected by COVID-19: the potential role of immunosenescence and CMV. Rev Med Virol 30(5):e2144</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2144</ArticleId></ArticleIdList></Reference><Reference><Citation>Karahan S, Katkat F (2021) Impact of serum 25 (OH) vitamin D level on mortality in patients with COVID-19 in Turkey. J Nutr Health Aging 25(2):189–196</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12603-020-1479-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufman HW, Niles JK, Kroll MH, Bi C, Holick MF (2020) SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels. PLoS ONE 15(9):e0239252</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0239252</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennel KA, Drake MT, Hurley DL (2010) Vitamin D deficiency in adults: when to test and how to treat. Mayo Clin Proc 85(8):752–7</Citation><ArticleIdList><ArticleId IdType="doi">10.4065/mcp.2010.0138</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan S, Tombuloglu H, Hassanein SE, Rehman S, Bozkurt A, Cevik E et al (2020) Coronavirus diseases 2019: current biological situation and potential therapeutic perspective. Eur J Pharmacol 886:173447</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2020.173447</ArticleId></ArticleIdList></Reference><Reference><Citation>Khazai N, Judd SE, Tangpricha V (2008) Calcium and vitamin D: skeletal and extraskeletal health. Curr Rheumatol Rep 10(2):110–117</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11926-008-0020-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheiri B, Abdalla A, Osman M, Ahmed S, Hassan M, Bachuwa G (2018) Vitamin D deficiency and risk of cardiovascular diseases: a narrative review. Clin Hypertens 24:9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40885-018-0094-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Kow CS, Hadi MA, Hasan SS (2020) Vitamin D supplementation in influenza and COVID-19 infections comment on: “Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths” nutrients 2020, 12 (4), 988. Nutrients 12(6):1626</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12061626</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar R, Rathi H, Haq A, Wimalawansa SJ, Sharma A (2021) Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19. Virus Res 292:198235</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2020.198235</ArticleId></ArticleIdList></Reference><Reference><Citation>Lakkireddy M, Gadiga S, Malathi R, Karra M, Prasad Murthy Raju ISSV (2021) Impact of daily high dose oral vitamin D therapy on the inflammatory markers in patients with COVID 19 disease. Sci Rep 11(1):10641</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-90189-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau FH, Majumder R, Torabi R, Saeg F, Hoffman R, Cirillo JD et al (2020) Vitamin D insufficiency is prevalent in severe COVID-19. MedRxiv. https://doi.org/10.1101/2020.04.24.20075838</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.04.24.20075838</ArticleId></ArticleIdList></Reference><Reference><Citation>LeFevre ML (2015) Screening for vitamin D deficiency in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 162(2):133–40</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M14-2450</ArticleId></ArticleIdList></Reference><Reference><Citation>MacLaughlin J, Holick MF (1985) Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 76(4):1536–1538</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI112134</ArticleId></ArticleIdList></Reference><Reference><Citation>Maghbooli Z, Sahraian MA, Jamalimoghadamsiahkali S, Asadi A, Zarei A, Zendehdel A et al (2021) Treatment with 25-hydroxyvitamin D3 (calcifediol) is associated with a reduction in the blood neutrophil-to-lymphocyte ratio marker of disease severity in hospitalized patients with COVID-19: a pilot multicenter, randomized, placebo-controlled, double-blinded clinical trial. Endocr Pract 27(12):1242–1251</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eprac.2021.09.016</ArticleId></ArticleIdList></Reference><Reference><Citation>Malabanan A, Veronikis IE, Holick MF (1998) Redefining vitamin D insufficiency. Lancet 351(9105):805–806</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(05)78933-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Malloy PJ, Peng L, Wang J, Feldman D (2009) Interaction of the vitamin D receptor with a vitamin D response element in the Müllerian-inhibiting substance (MIS) promoter: regulation of MIS expression by calcitriol in prostate cancer cells. Endocrinology 150(4):1580–1587</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/en.2008-1555</ArticleId></ArticleIdList></Reference><Reference><Citation>Małyszko J, Tomaszuk-Kazberuk A, Dobrzycki K, Bachórzewska-Gajewska H, Zorawski M, Koc-Zorawska E et al (2019) Vitamin D deficiency and anemia is highly prevalent and dependent on the etiology of heart failure: a pilot study. Cardiol J. https://doi.org/10.5603/CJ.a2019.0003</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/CJ.a2019.0003</ArticleId></ArticleIdList></Reference><Reference><Citation>Mamurova B, Akan G, Mogol E, Turgay A, Tuncel G, Evren EU et al (2023) Strong association between vitamin D receptor gene and severe acute respiratory syndrome coronavirus 2 infectious variants. Glob Med Genet 10(01):27–33</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0043-1761924</ArticleId></ArticleIdList></Reference><Reference><Citation>Manson JE, Brannon PM, Rosen CJ, Taylor CL (2016) Vitamin D deficiency—is there really a pandemic? N Engl J Med 375(19):1817–1820</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp1608005</ArticleId></ArticleIdList></Reference><Reference><Citation>Martineau AR, Jolliffe DA, Greenberg L, Aloia JF, Bergman P, Dubnov-Raz G et al (2019) Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis. Health Technol Assess 23(2):1–44</Citation><ArticleIdList><ArticleId IdType="doi">10.3310/hta23020</ArticleId></ArticleIdList></Reference><Reference><Citation>Matyjaszek-Matuszek B, Lenart-Lipińska M, Woźniakowska E (2015) Clinical implications of vitamin D deficiency. Menopause Rev 14(2):75–81</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/pm.2015.52149</ArticleId></ArticleIdList></Reference><Reference><Citation>Mbata MK, Hunziker M, Makhdoomi A, Lüthi-Corridori G, Boesing M, Giezendanner S et al (2023) Is serum 25-hydroxyvitamin d level associated with severity of COVID-19? A retrospective study. J Clin Med 12(17):5520</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12175520</ArticleId></ArticleIdList></Reference><Reference><Citation>Meckel K, Li YC, Lim J, Kocherginsky M, Weber C, Almoghrabi A et al (2016) Serum 25-hydroxyvitamin D concentration is inversely associated with mucosal inflammation in patients with ulcerative colitis. Am J Clin Nutr 104(1):113–120</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/ajcn.115.123786</ArticleId></ArticleIdList></Reference><Reference><Citation>Meftahi GH, Jangravi Z, Sahraei H, Bahari Z (2020) The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of “inflame-aging.” Inflamm Res 69(9):825–839</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-020-01372-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercola J, Grant WB, Wagner CL (2020) Evidence regarding vitamin D and risk of COVID-19 and its severity. Nutrients 12(11):3361</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12113361</ArticleId></ArticleIdList></Reference><Reference><Citation>Merzon E, Tworowski D, Gorohovski A, Vinker S, Golan Cohen A, Green I et al (2020) Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study. FEBS J 287(17):3693–3702</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.15495</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyerowitz EA, Scott J, Richterman A, Male V, Cevik M (2024) Clinical course and management of COVID-19 in the era of widespread population immunity. Nat Rev Microbiol 22(2):75–88</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-023-01001-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Mezza T, Muscogiuri G, Sorice GP, Prioletta A, Salomone E, Pontecorvi A et al (2012) Vitamin D deficiency: a new risk factor for type 2 diabetes? Ann Nutr Metab 61(4):337–348</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000342771</ArticleId></ArticleIdList></Reference><Reference><Citation>Miroliaee AE, Salamzadeh J, Shokouhi S, Sahraei Z (2018) The study of vitamin D administration effect on CRP and Interleukin-6 as prognostic biomarkers of ventilator associated pneumonia. J Crit Care 44:300–305</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2017.08.040</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizwicki MT, Norman AW (2009) The vitamin D sterol-vitamin D receptor ensemble model offers unique insights into both genomic and rapid-response signaling. Sci Signal 2(75):re4</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.275re4</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohan M, Cherian JJ, Sharma A (2020) Exploring links between vitamin D deficiency and COVID-19. PLoS Pathog 16(9):e1008874</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008874</ArticleId></ArticleIdList></Reference><Reference><Citation>Molnár F, Peräkylä M, Carlberg C (2006) Vitamin D receptor agonists specifically modulate the volume of the ligand-binding pocket. J Biol Chem 281(15):10516–10526</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M513609200</ArticleId></ArticleIdList></Reference><Reference><Citation>Molnár F, Sigüeiro R, Sato Y, Araujo C, Schuster I, Antony P et al (2011) 1α,25(OH)2-3-epi-vitamin D3, a natural physiological metabolite of vitamin D3: its synthesis, biological activity and crystal structure with its receptor. PLoS ONE 6(3):e18124</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0018124</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulligan GB, Licata A (2010) Taking vitamin D with the largest meal improves absorption and results in higher serum levels of 25-hydroxyvitamin D. J Bone Miner Res 25(4):928–930</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.67</ArticleId></ArticleIdList></Reference><Reference><Citation>Murai IH, Fernandes AL, Sales LP, Pinto AJ, Goessler KF, Duran CS et al (2020) Effect of vitamin D3 supplementation vs placebo on hospital length of stay in patients with severe COVID-19: a multicenter, double-blind, randomized controlled trial. Medrxiv. https://doi.org/10.1101/2020.11.16.20232397</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.11.16.20232397</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagpal S, Na S, Rathnachalam R (2005) Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 26(5):662–687</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/er.2004-0002</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme J, Borghesan M, Mackedenski S, Bird TG, Demaria M (2020) Cellular senescence as a potential mediator of COVID-19 severity in the elderly. Aging Cell 19(10):e13237</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.13237</ArticleId></ArticleIdList></Reference><Reference><Citation>Niraj N, Mahajan SS, Prakash A, Sarma P, Medhi B (2022) Paxlovid: a promising drug for the challenging treatment of SARS-COV-2 in the pandemic era. Indian J Pharmacol 54(6):452–458</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijp.ijp_291_22</ArticleId></ArticleIdList></Reference><Reference><Citation>Norman AW (2006) Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology 147(12):5542–5548</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/en.2006-0946</ArticleId></ArticleIdList></Reference><Reference><Citation>Norman AW (2008) From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 88(2):491s-s499</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/88.2.491S</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong LTC, Booth DR, Parnell GP (2020) Vitamin D and its effects on DNA methylation in development, aging, and disease. Mol Nutr Food Res. 64:e2000437</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mnfr.202000437</ArticleId></ArticleIdList></Reference><Reference><Citation>Orchard L, Baldry M, Nasim-Mohi M, Monck C, Saeed K, Grocott MPW et al (2021) Vitamin D levels and intensive care unit outcomes of a cohort of critically ill COVID-19 patients. Clin Chem Lab Med. https://doi.org/10.1515/cclm-2020-1567</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2020-1567</ArticleId></ArticleIdList></Reference><Reference><Citation>Owen DR, Allerton CMN, Anderson AS, Aschenbrenner L, Avery M, Berritt S et al (2021) An oral SARS-CoV-2 M(pro) inhibitor clinical candidate for the treatment of COVID-19. Science 374(6575):1586–1593</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abl4784</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal R, Bhadada SK (2020) COVID-19 and diabetes mellitus: an unholy interaction of two pandemics. Diabetes Metab Syndr 14(4):513–517</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.04.049</ArticleId></ArticleIdList></Reference><Reference><Citation>Panagiotou G, Tee SA, Ihsan Y, Athar W, Marchitelli G, Kelly D et al (2020) Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalized with COVID-19 are associated with greater disease severity. Clin Endocrinol 93(4):508–511</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cen.14276</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng D, Huang H, Liu Z, Gao Y, Liu Y (2022) Vitamin D levels and clinical outcomes of SARS-CoV-2 Omicron subvariant BA.2 in children: a longitudinal cohort study. Front Nutr 9:960859</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2022.960859</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira M, Dantas Damascena A, Galvão Azevedo LM, de Almeida Oliveira T, da Mota Santana J (2020) Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis. Crit Rev Food Sci Nutr 62:1–9</Citation></Reference><Reference><Citation>Perrotta F, Corbi G, Mazzeo G, Boccia M, Aronne L, D’Agnano V et al (2020) COVID-19 and the elderly: insights into pathogenesis and clinical decision-making. Aging Clin Exp Res 32(8):1599–1608</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-020-01631-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Pike JW, Meyer MB (2010) The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D(3). Endocrinol Metab Clin North Am 39(2):255–69</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ecl.2010.02.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Prietl B, Treiber G, Pieber TR, Amrein K (2013) Vitamin D and immune function. Nutrients 5(7):2502–2521</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu5072502</ArticleId></ArticleIdList></Reference><Reference><Citation>Rastogi A, Bhansali A, Khare N, Suri V, Yaddanapudi N, Sachdeva N et al (2022) Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study). Postgrad Med J 98(1156):87–90</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/postgradmedj-2020-139065</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehman S, Majeed T, Azam Ansari M, Ali U, Sabit H, Al-Suhaimi EA (2020) Current scenario of COVID-19 in pediatric age group and physiology of immune and thymus response. Saudi J Biol Sci 27(10):2567–2573</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sjbs.2020.05.024</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes JM, Subramanian S, Laird E, Griffin G, Kenny RA (2021a) Perspective: vitamin D deficiency and COVID-19 severity—plausibly linked by latitude, ethnicity, impacts on cytokines, ACE 2 and thrombosis. J Intern Med 289(1):97–115</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13149</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes JM, Subramanian S, Laird E, Griffin G, Kenny RA (2021b) Perspective: vitamin D deficiency and COVID-19 severity – plausibly linked by latitude, ethnicity, impacts on cytokines, ACE2 and thrombosis. J Intern Med 289(1):97–115</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13149</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard A, Rohrmann S, Quack Lötscher KC (2017) Prevalence of vitamin D deficiency and its associations with skin color in pregnant women in the first trimester in a sample from Switzerland. Nutrients 9(3):260</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu9030260</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen CJ, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA et al (2012) IOM committee members respond to Endocrine Society vitamin D guideline. J Clin Endocrinol Metab 97(4):1146–1152</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2011-2218</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabico S, Enani MA, Sheshah E, Aljohani NJ, Aldisi DA, Alotaibi NH et al (2021) Effects of a 2-week 5000 IU versus 1000 IU vitamin D3 supplementation on recovery of symptoms in patients with mild to moderate Covid-19: a randomized clinical trial. Nutrients 13(7):2170</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13072170</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarhan N, Abou Warda AE, Sarhan RM, Boshra MS, Mostafa-Hedeab G, ALruwaili BF et al (2022) Evidence for the efficacy of a high dose of vitamin D on the hyperinflammation state in moderate-to-severe COVID-19 patients: a randomized clinical trial. Medicina 58(10):1358</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58101358</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahid Z, Kalayanamitra R, McClafferty B, Kepko D, Ramgobin D, Patel R et al (2020) COVID-19 and older adults: what we know. J Am Geriatr Soc 68(5):926–929</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.16472</ArticleId></ArticleIdList></Reference><Reference><Citation>Sidiropoulou P, Docea AO, Nikolaou V, Katsarou MS, Spandidos DA, Tsatsakis A et al (2021) Unraveling the roles of vitamin D status and melanin during Covid-19 (review). Int J Mol Med 47(1):92–100</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2020.4802</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh SK, Jain R, Singh S (2020a) Vitamin D deficiency in patients with diabetes and COVID-19 infection. Diabetes Metab Syndr 14(5):1033–1035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.06.071</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh AK, Gupta R, Ghosh A, Misra A (2020b) Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr 14(4):303–310</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.04.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Snegarova V, Naydenova D (2020) Vitamin D: a review of its effects on epigenetics and gene regulation. Folia Med 62(4):662–667</Citation><ArticleIdList><ArticleId IdType="doi">10.3897/folmed.62.e50204.</ArticleId></ArticleIdList></Reference><Reference><Citation>Speeckaert MM, Delanghe JR (2020) Association between low vitamin D and COVID-19: don’t forget the vitamin D binding protein. Aging Clin Exp Res 32(7):1207–1208</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-020-01607-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Sung CC, Liao MT, Lu KC, Wu CC (2012) Role of vitamin D in insulin resistance. J Biomed Biotechnol 2012:634195</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/634195</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutton AL, MacDonald PN (2003) Vitamin D: more than a “bone-a-fide” hormone. Mol Endocrinol 17(5):777–791</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/me.2002-0363</ArticleId></ArticleIdList></Reference><Reference><Citation>Szymczak-Pajor I, Drzewoski J, Śliwińska A (2020) The molecular mechanisms by which vitamin D prevents insulin resistance and associated disorders. Int J Mol Sci 21(18):6644</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21186644</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CW, Ho LP, Kalimuddin S, Cherng BPZ, Teh YE, Thien SY et al (2020) A cohort study to evaluate the effect of combination vitamin D, magnesium and vitamin B12 (DMB) on progression to severe outcome in older COVID-19 patients. MedRxiv. https://doi.org/10.1016/j.nut.2020.111017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2020.111017</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A (2007) Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 370(9588):657–666</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(07)61342-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Tony MA, Nabwey HA (2024) Recent advances in solar still technology for solar water desalination. Appl Water Sci 14(7):147</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13201-024-02188-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdivielso JM (2009) The physiology of vitamin D receptor activation. Contrib Nephrol 163:206–212</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000223800</ArticleId></ArticleIdList></Reference><Reference><Citation>van Etten E, Mathieu C (2005) Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol 97(1–2):93–101</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsbmb.2005.06.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassiliou AG, Jahaj E, Pratikaki M, Orfanos SE, Dimopoulou I, Kotanidou A (2020) Low 25-hydroxyvitamin D levels on admission to the intensive care unit may predispose COVID-19 pneumonia patients to a higher 28-day mortality risk: a pilot study on a Greek ICU cohort. Nutrients 12(12):3773</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12123773</ArticleId></ArticleIdList></Reference><Reference><Citation>Veldurthy V, Wei R, Oz L, Dhawan P, Jeon YH, Christakos S (2016) Vitamin D, calcium homeostasis and aging. Bone Res 4:16041</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/boneres.2016.41</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieth R (1999) Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 69(5):842–856</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/69.5.842</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T, Liu Z, Fu J, Min Z (2019) Meta-analysis of vitamin D supplementation in the treatment of chronic heart failure. Scand Cardiovasc J 53(3):110–116</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14017431.2019.1612084</ArticleId></ArticleIdList></Reference><Reference><Citation>Wasserman RH (2004) Vitamin D and the dual processes of intestinal calcium absorption. J Nutr 134(11):3137–3139</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jn/134.11.3137</ArticleId></ArticleIdList></Reference><Reference><Citation>Watts KM, Lahiri P, Arrazuria R, De Buck J, Knight CG, Orsel K et al (2020) Oxytetracycline reduces inflammation and treponeme burden whereas vitamin D 3 promotes β-defensin expression in bovine infectious digital dermatitis. Cell Tissue Res 379(2):337</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-019-03082-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb AR (2006) Who, what, where and when—influences on cutaneous vitamin D synthesis. Prog Biophys Mol Biol 92(1):17–25</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pbiomolbio.2006.02.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Weir EK, Thenappan T, Bhargava M, Chen Y (2020) Does vitamin D deficiency increase the severity of COVID-19? Clin Med 20(4):e107–e108</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0301</ArticleId></ArticleIdList></Reference><Reference><Citation>Welch AA, Skinner J, Hickson M (2017) Dietary magnesium may be protective for aging of bone and skeletal muscle in middle and younger older age men and women: cross-sectional findings from the UK Biobank cohort. Nutrients 9(11):1189</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu9111189</ArticleId></ArticleIdList></Reference><Reference><Citation>Wimalawansa SJ, Vitamin D (2019) Deficiency: effects on oxidative stress, epigenetics, gene regulation, and aging. Biology 8(2):30</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology8020030</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J, Yang J, Chen J, Luo Q, Zhang Q, Zhang H (2017) Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the renin-angiotensin system. Mol Med Rep 16(5):7432–7438</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2017.7546</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye K, Tang F, Liao X, Shaw BA, Deng M, Huang G et al (2021) Does serum vitamin D level affect COVID-19 infection and its severity?—A case-control study. J Am Coll Nutr 40(8):724–731</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07315724.2020.1826005</ArticleId></ArticleIdList></Reference><Reference><Citation>Yisak H, Ewunetei A, Kefale B, Mamuye M, Teshome F, Ambaw B et al (2021) Effects of vitamin D on COVID-19 infection and prognosis: a systematic review. Risk Manag Healthc Policy 14:31–38</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/RMHP.S291584</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Leung DY, Richers BN, Liu Y, Remigio LK, Riches DW et al (2012) Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol 188(5):2127–2135</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1102412</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou R, Chun RF, Lisse TS, Garcia AJ, Xu J, Adams JS et al (2015) Vitamin D and alternative splicing of RNA. J Steroid Biochem Mol Biol 148:310–317</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsbmb.2014.09.025</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu JG, Ochalek JT, Kaufmann M, Jones G, Deluca HF (2013) CYP2R1 is a major, but not exclusive, contributor to 25-hydroxyvitamin D production in vivo. Proc Natl Acad Sci U S A 110(39):15650–15655</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1315006110</ArticleId></ArticleIdList></Reference><Reference><Citation>Zittermann A, Schleithoff SS, Koerfer R (2006) Vitamin D insufficiency in congestive heart failure: why and what to do about it? Heart Fail Rev 11(1):25–33</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10741-006-9190-8</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>